Cadrenal Therapeutics (CVKD) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Price: $1.16 -3.33%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Cadrenal Therapeutics (NASDAQ: CVKD) to $13.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Scott Bessent will not be going to be super intelligence (SI) czar
- Araghchi gave Witkoff and Kushner Iran's conditions for reopening the Strait of Hormuz and resuming nuclear talks - Axios
- GoDaddy (GDDY) Reiterated at Buy by StoneX on Reports of Takeover Offer
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
